Gut Microbial Metabolites As Mediators of Renal Disease: do Short-Chain Fatty Acids Offer Some Hope?

References

• SarnakMJ, LeveyAS, SchoolwerthAC et al.Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension42(5), 1050–1065 (2003).
   PubMed Web of Science ®Google Scholar
• LevinA, StevensPE, BilousRW et al.Kidney Disease: Improving Global Outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl.3(1), 1–150 (2013).
   Web of Science ®Google Scholar
• KerrM, BrayB, MedcalfJ, O’DonoghueDJ, MatthewsB. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol. Dial. Transplant.27(Suppl. 3), iii73–80 (2012).
   PubMed Web of Science ®Google Scholar
• WebsterAC, NaglerEV, MortonRL, MassonP. Chronic kidney disease. Lancet389, 1238–1252 (2017).
   PubMed Web of Science ®Google Scholar
• LynchSV, PedersenO. The human intestinal microbiome in health and disease. N. Engl. J. Med.375(24), 2369–2379 (2016).
   PubMed Web of Science ®Google Scholar
• AlKhodor S, ShatatIF. Gut microbiome and kidney disease: a bidirectional relationship. Pediatr. Nephrol.32(6), 921–931 (2017).
   PubMed Web of Science ®Google Scholar
• WuIW, HsuKH, LeeCC et al.P-cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant.26(3), 938–947 (2011).
   PubMed Web of Science ®Google Scholar
• deFaria Barros A, BorgesNA, NakaoLS et al.Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: a double-blind, randomized, placebo-controlled trial. J. Funct. Foods46, 378–383 (2018).
   Web of Science ®Google Scholar
• MeijersBKI, ClaesK, BammensB et al.p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin. J. Am. Soc. Nephrol.5(7), 1182–1189 (2010).
   PubMed Web of Science ®Google Scholar
• BammensB, EvenepoelP, KeuleersH, VerbekeK, VanrenterghemY. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int.69(6), 1081–1087 (2006).
   PubMed Web of Science ®Google Scholar
• KoethRA, WangZ, LevisonBS et al.Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med.19(5), 576–585 (2013).
   PubMed Web of Science ®Google Scholar
• OrganCL, OtsukaH, BhushanS et al.Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure. Circ. Hear. Fail.9(1) (2016).
   PubMed Web of Science ®Google Scholar
• SuzukiT, HeaneyLM, BhandariSS, JonesDJL, NgLL. Trimethylamine N-oxide and prognosis in acute heart failure. Heart102(11), 841–848 (2016).
   PubMed Web of Science ®Google Scholar
• SuzukiT, HeaneyLM, JonesDJL, NgLL. Trimethylamine N-oxide and risk stratification after acute myocardial infarction. Clin. Chem.63(1), 420–428 (2017).
   PubMed Web of Science ®Google Scholar
• TangWHW, WangZ, KennedyDJ et al.Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res.116(3), 448–455 (2015).
   PubMed Web of Science ®Google Scholar
• MissailidisC, HällqvistJ, QureshiAR et al.Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PLoS ONE11(1), 1–14 (2016).
   Web of Science ®Google Scholar
• TomlinsonJAP, WheelerDC. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease. Kidney Int.92(4), 809–815 (2017).
   PubMed Web of Science ®Google Scholar
• HuangW, ZhouL, GuoH, XuY, XuY. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response. Metabolism68, 20–30 (2017).
   PubMed Web of Science ®Google Scholar
• MatsumotoN, RileyS, FraserD et al.Butyrate modulates TGF-β1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM™ (gum arabic)?Kidney Int.69(2), 257–265 (2006).
   PubMed Web of Science ®Google Scholar
• KhanS, JenaG. Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats. Food Chem. Toxicol.73, 127–139 (2014).
   PubMed Web of Science ®Google Scholar
• MacHadoRA, ConstantinoLDS, TomasiCD et al.Sodium butyrate decreases the activation of NF-κB reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathy. Nephrol. Dial. Transplant.27(8), 3136–3140 (2012).
   PubMed Web of Science ®Google Scholar
• KobayashiM, MikamiD, KimuraH et al.Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-α-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells. Biochem. Biophys. Res. Commun.486(2), 499–505 (2017).
   PubMed Web of Science ®Google Scholar
• Al-HarbiNO, NadeemA, AhmadSF et al.Short chain fatty acid, acetate ameliorates sepsis-induced acute kidney injury by inhibition of NADPH oxidase signaling in T cells. Int. Immunopharmacol.58, 24–31 (2018).
   PubMed Web of Science ®Google Scholar
• Andrade-OliveiraV, AmanoMT, Correa-CostaM et al.Gut bacteria products prevent AKI induced by ischemia-reperfusion. J. Am. Soc. Nephrol.26(8), 1877–1888 (2015).
   PubMed Web of Science ®Google Scholar
• VaziriND, LiuSM, LauWL et al.High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS ONE9(12), e114881 (2014).
   PubMed Web of Science ®Google Scholar
• KiefferDA, PiccoloBD, VaziriND et al.Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am. J. Physiol. Physiol.310(9), F857–F871 (2016).
   PubMed Web of Science ®Google Scholar
• LiQ, WuT, LiuR, ZhangM, WangR. Soluble dietary fiber reduces trimethylamine metabolism via gut microbiota and co-regulates host AMPK pathways. Mol. Nutr. Food Res.61(12), 1700473 (2017).
   Web of Science ®Google Scholar